Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

Migration von ZORA auf die Software DSpace

ZORA will change to a new software on 8th September 2025. Please note: deadline for new submissions is 21th July 2025!

Information & dates for training courses can be found here: Information on Software Migration.

A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement

Slight, Sarah Patricia; Beeler, Patrick E; Seger, Diane L; Amato, Mary G; Her, Qoua L; Swerdloff, Michael; Dalleur, Olivia; Nanji, Karen C; Cho, InSook; Maniam, Nivethietha; Eguale, Tewodros; Fiskio, Julie M; Dykes, Patricia C; Bates, David W (2017). A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement. BMJ Quality and Safety, 26(3):217-225.

Abstract

OBJECTIVES: To evaluate how often and why providers overrode drug allergy alerts in both the inpatient and outpatient settings.
DESIGN: A cross-sectional observational study of drug allergy alerts generated over a 3-year period between 1 January 2009 and 31 December 2011.
SETTING: A 793-bed tertiary care teaching affiliate of Harvard Medical School and 36 primary care practices.
PARTICIPANTS: Drug allergy alerts were displayed for a total of 29 420 patients across both settings.
MAIN OUTCOME MEASURES: Proportion of drug allergy alerts displayed and overridden, proportion of appropriate overrides, proportion of overrides in each medication class, different reasons for overriding and types of reactions overridden.
RESULTS: A total of 158 023 drug allergy alerts were displayed, 131 615 (83%) in the inpatient setting and 26 408 (17%) in the outpatient setting; 128 157 (81%) of which were overridden. A random sample of inpatient (n=200, 0.19%) and outpatient (n=50, 0.25%) alert overrides were screened for appropriateness, with >96% considered appropriate. Alerts for some drug classes, such as 'non-antibiotic sulfonamides', were overridden for >81% of prescriptions in both settings. The most common override reason was patient has taken previously without allergic reaction. In the inpatient setting alone, 70.9% of alerts that warned against the risk of anaphylaxis were overridden.
CONCLUSIONS: The information contained in patients' drug allergy lists needs to be regularly updated. Most of the drug allergy alerts were overridden, with the majority of alert overrides in the subsample considered appropriate. Some of the rules for these alerts should be carefully reviewed and modified, or removed. Further research is needed to understand providers' overriding of alerts that warned against the risk of 'anaphylaxis', which are more concerning with respect to patient safety.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Center on Aging and Mobility
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Scopus Subject Areas:Health Sciences > Health Policy
Language:English
Date:2017
Deposited On:06 May 2016 16:02
Last Modified:14 Jun 2025 01:37
Publisher:BMJ Publishing Group
ISSN:2044-5415
OA Status:Green
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1136/bmjqs-2015-004851
PubMed ID:26993641
Download PDF  'A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement'.
Preview
  • Content: Accepted Version
  • Language: English

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
33 citations in Web of Science®
34 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

132 downloads since deposited on 06 May 2016
5 downloads since 12 months
Detailed statistics

Authors, Affiliations, Collaborations

Similar Publications